Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties.
about
Protein nanoparticles as drug delivery carriers for cancer therapyBSA nanoparticle loaded atorvastatin calcium--a new facet for an old drugHuman serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysisPreparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles.Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology.Nanotechnology in oncology: Characterization and in vitro release kinetics of cisplatin-loaded albumin nanoparticles: Implications in anticancer drug delivery.Comparison of Different Crosslinking Methods for Preparation of Docetaxel-loaded Albumin NanoparticlesTransporter-targeted lipid prodrugs of cyclic cidofovir: a potential approach for the treatment of cytomegalovirus retinitis.Comparison of protein- and polysaccharide-based nanoparticles for cancer therapy: synthesis, characterization, drug release, and interaction with a breast cancer cell line.5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release studyMicro/nanostructured polymeric systems for biomedical and pharmaceutical applications.Combined computational and experimental studies of molecular interactions of albuterol sulfate with bovine serum albumin for pulmonary drug nanoparticles.The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers.Ocular drug delivery system: a reference to natural polymers.Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective.Recent trends in drug delivery system using protein nanoparticles.A sight on protein-based nanoparticles as drug/gene delivery systems.Application of albumin-based nanoparticles in the management of cancer.Albumin nanostructures as advanced drug delivery systems.Formulation development and evaluation of hybrid nanocarrier for cancer therapy: Taguchi orthogonal array based design.Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems.Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution.Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration.Galactosylated albumin nanoparticles of simvastatin.Additive-free albumin nanoparticles of alendronate for attenuating inflammation through monocyte inhibition.Reversal of Vascular Calcification and Aneurysms in a Rat Model Using Dual Targeted Therapy with EDTA- and PGG-Loaded NanoparticlesRing-opening polymerization of ε-caprolactone initiated by ganciclovir (GCV) for the preparation of GCV-tagged polymeric micelles.The Effects of Organic Solvents on the Physicochemical Properties of Human Serum Albumin Nanoparticles.Polycaprolactone scaffold engineered for sustained release of resveratrol: therapeutic enhancement in bone tissue engineering.Albumin nanoparticles coated with polysorbate 80 as a novel drug carrier for the delivery of antiretroviral drug-Efavirenz.Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib.Radical crosslinked albumin microspheres as potential drug delivery systems: preparation and in vitro studies.Radical cross-linked albumin microspheres as potential drug delivery systems: preparation and in vitro studies.Systemic Delivery of Nanoparticles Loaded with Pentagalloyl Glucose Protects Elastic Lamina and Prevents Abdominal Aortic Aneurysm in Rats.Albumin Nanoparticles for Brain Delivery: A Comparison of Chemical versus Thermal Methods and in vivo Behavior.Protein-Based Nanoparticle Preparation via Nanoprecipitation Method.
P2860
Q23923552-8D3FE0E6-1EC1-4DD3-92AE-B79718C5DF81Q28539424-787AFA62-2FF0-46E3-9830-EC85246117C5Q34170177-D1ABDBC8-B665-482C-980E-33A5DEBFF334Q34170184-71CA1631-D2A5-4172-929E-D55117CC15F1Q34280232-D293ECE8-0604-4A50-AC5B-8E71F2FC0D41Q35157105-1A82C281-15F6-4A82-BD39-C339AE268402Q35483895-F1629C6A-64E5-4348-8A59-A56B9FDE372AQ35892584-131C5477-5056-41E8-8845-D999EF5BED56Q35992063-D07027CF-5B7F-4195-886B-6D3E0BE76F61Q37065965-B7FF130B-FF53-42A6-AAD8-0E5BD95F78E1Q37176404-FFC88306-3570-479E-8B8E-D69F29D98C5CQ37269769-592DDA6A-671B-4A84-9D36-30DAACD78076Q37872313-C8B4BFD3-B220-4B4C-8DFF-276566370F3EQ38019052-3C7956D6-1B7D-4B66-9AED-682E566A1F19Q38066148-D232CF65-7850-459E-8A68-64BBBD1C7A76Q38199373-12E297B9-FA34-4F2E-A485-D265413DE973Q38573478-6FE27F1A-5182-4852-8C0A-E1710FBAD856Q38649063-4F2EEA60-564E-4D2C-B49D-BAD8BE18972AQ38842596-3267B4BE-BCEA-498A-A83C-B29F0C483926Q39084192-8DFCE779-F07B-4303-B548-D15C2BFFC2D5Q39257007-06BDE645-CDF7-4736-B3F3-A75442E1F780Q39455941-46A8420C-7330-42A7-8BDB-E41FEF1FC1D9Q39557309-69A27733-9885-4827-98EF-42D30DD81C39Q39739004-7F8A3F8D-55C2-4242-9BEA-F0578DE5D7E3Q39785552-FA6DECBD-F13C-4587-A350-46CBDB542EFDQ40090151-7C413F46-F636-4BC8-B15F-68FA0AFDF6CAQ41200985-774F99F7-12AD-4802-8421-591F3E5EF513Q41487730-04432739-B3C5-4E3F-BA7E-F869DBC6E8D9Q41674233-9B2DE2FF-24C5-45B1-AFEB-15FC747F8D9CQ41960585-6B49A075-B37F-4B0C-8A2B-56A260B30D33Q42199787-2E779D13-75BB-4384-9308-4C5295056022Q45683884-E8D29F62-DDA4-4843-B4D0-9D241E303749Q46605577-124BB299-9B09-499E-891A-674F2E398158Q46612728-EA047FB2-2CCE-48AC-A3CE-B0913E834224Q48104140-62879908-07F9-4A2A-9700-DB00968D9852Q48857181-33D4B5E7-E1BF-453E-9BBA-2FAE4B0DAC02Q51735208-CDFAEB38-0BD9-4522-8183-D2B3FEC4FCE7
P2860
Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Ganciclovir-loaded albumin nan ...... d in vitro release properties.
@ast
Ganciclovir-loaded albumin nan ...... d in vitro release properties.
@en
type
label
Ganciclovir-loaded albumin nan ...... d in vitro release properties.
@ast
Ganciclovir-loaded albumin nan ...... d in vitro release properties.
@en
prefLabel
Ganciclovir-loaded albumin nan ...... d in vitro release properties.
@ast
Ganciclovir-loaded albumin nan ...... d in vitro release properties.
@en
P2093
P1476
Ganciclovir-loaded albumin nan ...... nd in vitro release properties
@en
P2093
P304
P356
10.1016/S0928-0987(00)00169-X
P407
P577
2001-01-01T00:00:00Z